These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 681814)

  • 21. Correlation between N-acetyltransferase activities in uroepithelia and in vivo acetylator phenotype.
    Pink JC; Messing EM; Reznikoff CA; Bryan GT; Swaminathan S
    Drug Metab Dispos; 1992; 20(4):559-65. PubMed ID: 1356735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic acetylator phenotype in diabetes mellitus.
    Ladero JM; Arrojo A; de Salamanca RE; Gomez M; Cano F; Alfonso M
    Ann Clin Res; 1982 Aug; 14(4):187-9. PubMed ID: 7168549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoniazid acetylation phenotyping in Saudi Arabs.
    Matar KM; Mayet AY; Ayoola EA; Bawazir SA; Al-Faleh FZ; Al-Wazzan A
    J Clin Pharm Ther; 2004 Oct; 29(5):443-7. PubMed ID: 15482388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetylation phenotype status in a Bangladeshi population and its comparison with that of other Asian population data.
    Zaid RB; Nargis M; Neelotpol S; Hannan JM; Islam S; Akhter R; Ali L; Azad Khan AK
    Biopharm Drug Dispos; 2004 Sep; 25(6):237-41. PubMed ID: 15334622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
    William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
    Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple test for acetylator phenotype using caffeine.
    Grant DM; Tang BK; Kalow W
    Br J Clin Pharmacol; 1984 Apr; 17(4):459-64. PubMed ID: 6721992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products.
    Martell KJ; Levy GN; Weber WW
    Mol Pharmacol; 1992 Aug; 42(2):265-72. PubMed ID: 1513324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylator phenotype in patients with lung carcinoma--a negative report.
    Burgess EJ; Trafford JA
    Eur J Respir Dis; 1985 Jul; 67(1):17-9. PubMed ID: 4054252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caffeine acetylator phenotyping during maturation in infants.
    Pariente-Khayat A; Pons G; Rey E; Richard MO; D'Athis P; Moran C; Badoual J; Olive G
    Pediatr Res; 1991 May; 29(5):492-5. PubMed ID: 1896253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver.
    Hein DW; Rustan TD; Bucher KD; Martin WJ; Furman EJ
    Drug Metab Dispos; 1991; 19(5):933-7. PubMed ID: 1686239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-acetylation pharmacogenetics. Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo.
    Andres HH; Weber WW
    Drug Metab Dispos; 1986; 14(4):382-5. PubMed ID: 2873982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells.
    Frederickson SM; Messing EM; Reznikoff CA; Swaminathan S
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):25-32. PubMed ID: 8118381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylation.
    Weber WW
    Birth Defects Orig Artic Ser; 1990; 26(1):43-65. PubMed ID: 2224079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of co-trimazine after single and multiple doses.
    Leone N; Barzaghi N; Monteleone M; Perucca E; Cerutti R; Crema A
    Arzneimittelforschung; 1987 Jan; 37(1):70-4. PubMed ID: 3566861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Determination of the phenotype of N-acetyltransferase activity].
    Bulovskaia LN; Borisenko GN; Drobachenko OA; Kurbatova GP; Ivanova VV
    Lab Delo; 1990; (10):28-30. PubMed ID: 1704451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of arylhydroxamic acid N,O-acyltransferase and genetically polymorphic N-acetyltransferase in established inbred rabbit strains.
    Weber WW; Hein DW; Glowinski IB; King CM; Fox RR
    IARC Sci Publ; 1982; (39):405-12. PubMed ID: 7152617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antinuclear antibodies related to acetylator phenotype in mice.
    Tannen RH; Weber WW
    J Pharmacol Exp Ther; 1980 Jun; 213(3):485-90. PubMed ID: 6970809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics, acetylation-deacetylation, renal clearance, and protein binding of sulphamerazine, N4-acetylsulphamerazine, and N4-trideuteroacetylsulphamerazine in 'fast' and 'slow' acetylators.
    Vree TB; Hekster CA; Baakman M; Janssen T; Oosterbaan M; Termond E; Tijhuis M
    Biopharm Drug Dispos; 1983; 4(3):271-91. PubMed ID: 6626702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the acetylation polymorphism in determining susceptibility of cultured rabbit hepatocytes to DNA damage by aromatic amines.
    McQueen CA; Maslansky CJ; Williams GM
    Cancer Res; 1983 Jul; 43(7):3120-3. PubMed ID: 6850620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.